Showing results (301-310 of 445) with videos related to
Sort By:
Pageof 45
British Journal of Cancer|April 12, 2007
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAXO Nehls, T Okech, C-J Hsieh, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2008
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische OnkologieS-E Al-Batran, J T Hartmann, R Hofheinz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2007
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international studyK Fizazi, J Oldenburg, A Dunant, et al.European Journal of Cancer (Oxford, England : 1990)|October 16, 2012
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)Salah-Eddin Al-Batran, Claudia Pauligk, Nils Homann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancerO Rick, C Bokemeyer, J Beyer, et al.European Journal of Cancer (Oxford, England : 1990)|July 2, 2016
Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO)Thomas Schmitt, Regine Mayer-Steinacker, Frank Mayer, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)G Folprecht, T Gruenberger, W Bechstein, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 27, 2026
Rethinking Bacterial Osteolysis: Translational Evidence From a Porcine Model and Fracture-Related InfectionsAnton A N Peterlin, Nicole L Henriksen, Julie M Birch, et al.Der Pathologe|August 17, 2010
[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"]A V Rüsseler, B Brors, T Fischer, et al.The Lancet. Oncology|November 28, 2009
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trialGunnar Folprecht, Thomas Gruenberger, Wolf O Bechstein, et al.Pageof 45